Detail
Web resource
FT
Medvik - Catalogs
  • Something wrong with this record ?

Evidence to recommendations for COVID-19 vaccines : evidence framework : a framework to inform the assessment of evidence and formulation of subsequent COVID-19 vaccine recommendations : 10 December 2020

Published
[Geneva] : World Health Organization, 2020
©2020
Pagination
9 s.

Language English Country Switzerland

Persistent link   https://www.medvik.cz/link/MED00206089

As market-authorized COVID-19 vaccines become available, specific recommendations for the use of these vaccines will need to be issued. This SAGE evidence framework is intended to offer guidance for considering data emerging from clinical trials in support of issuing vaccine-specific evidence-based recommendations. This information is valuable to countries and regions developing COVID-19 vaccination recommendations.

Bibliography, etc.

Obsahuje bibliografické odkazy

Owner Details Services
NLK NLK Shelf no. online [0] see E-resources
000      
00000nam a2200000 i 4500
001      
MED00206089
003      
CZ-PrNML
005      
20230209164849.0
008      
210204s2020 sz eo 000 0|eng||
009      
W
040    __
$a ABA008 $b cze $d ABA008 $e rda
041    0_
$a eng
044    __
$a sz
072    _7
$a 614 $x Veřejné zdraví a hygiena $2 Konspekt $9 14 $7 sk136314
110    2_
$a Světová zdravotnická organizace $7 kn20010711442
245    10
$a Evidence to recommendations for COVID-19 vaccines : $b evidence framework : a framework to inform the assessment of evidence and formulation of subsequent COVID-19 vaccine recommendations : 10 December 2020
264    _1
$a [Geneva] : $b World Health Organization, $c 2020
264    _4
$c ©2020
300    __
$a 9 s.
336    __
$a text $b txt $2 rdacontent
337    __
$a počítač $b c $2 rdamedia
338    __
$a online zdroj $b cr $2 rdacarrier
347    __
$a textový soubor $b PDF $2 rda
504    __
$a Obsahuje bibliografické odkazy
520    3_
$a As market-authorized COVID-19 vaccines become available, specific recommendations for the use of these vaccines will need to be issued. This SAGE evidence framework is intended to offer guidance for considering data emerging from clinical trials in support of issuing vaccine-specific evidence-based recommendations. This information is valuable to countries and regions developing COVID-19 vaccination recommendations.
650    07
$a veřejné zdravotnictví $7 nlk20040148357 $2 mednas
650    07
$a COVID-19 $7 D000086382 $2 czmesh
650    07
$a Betacoronavirus $7 D000073640 $2 czmesh
650    07
$a epidemický výskyt choroby $7 D004196 $2 czmesh
650    07
$a vakcinace $7 D014611 $2 czmesh
650    07
$a očkovací programy $7 D017589 $2 czmesh
650    07
$a pokrytí očkováním $7 D000073887 $2 czmesh
650    07
$a medicína založená na důkazech $7 D019317 $2 czmesh
655    _4
$a publikace WHO $7 nlk20040156070
856    41
$u https://www.who.int/publications/i/item/WHO-2019-nCoV-SAGE-Framework-Evidence-2020-1 $y plný text volně přístupný
910    __
$a ABA008 $b online $y 0
990    __
$a 20210204132916 $b ABA008
991    __
$a 20230209164841 $b ABA008
999    __
$a ok $b medvik21 $g 1617366 $s 221864
BAS    __
$a 30 $a 49
LZP    __
$b 2021online
Back